| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |